Table 3.
Formulation | AST (U/L) | ALT (U/L) | CRE | BUN |
---|---|---|---|---|
Negative control | 15.26±0.405 | 27.89±5.51 | 22.10±6.63 | 11.44±2.38 |
PTX injection (4 mg/kg, iv) | 16.92±0.484* | 36.96±8.54 | 21.47±5.09 | 5.96±1.92* |
ACGs-NSps (0.4 mg/kg, iv) | 18.84±0.228*** | 33.89±8.38 | 22.57±6.26 | 4.83±1.45* |
FA-ACGs-NSps (0.4 mg/kg, iv) | 16.45±0.594 | 27.71±8.04 | 18.54±5.76 | 9.36±2.01 |
Notes: Results are presented as mean ± SD, n=10.
P<0.05,
P<0.001 versus normal saline.
Abbreviations: AST, aspartate transaminase; ALT, alanine aminotransferase; CRE, creatinine; BUN, blood urea nitrogen; PTX, paclitaxel; ACGs-NSps, Annonaceous acetogenins nanosuspensions; FA-ACGs-NSps, folic acid-modified ACGs-NSps; iv, intravenous; SD, standard deviation.